HOME >> BIOLOGY >> NEWS
Fortress America?

rlying strategy seems sensible. Normally companies don't make remedies for the rare diseases thought most likely to be used as weapons, as there is no profit in it. So BioShield promises companies that it will buy particular drugs and vaccines for the threats it fears most, in theory giving the companies an incentive to do the rest. Why, then, has the response so far has been so unimpressive? Project BioShield has awarded contracts for seven products, worth $2 billion. Two are for antibody-based therapies for botulism and anthrax. One is for 10 million doses of the military's existing anthrax vaccine a concoction of bacterial debris whose alleged side effects have led some soldiers to prefer court-martial to vaccination. The single biggest slice of funding, $878 million, has been pledged to VaxGen of Brisbane, California, for 75 million doses of a purer, new-generation anthrax vaccine. An order is also expected for 20 million doses of an improved smallpox vaccine from the Danish firm Bavarian Nordic, while Project BioShield has provided $4 million to universities to fund basic pathogen research.

This is new territory for a government agency, which may explain the slow start. "the government has never done anything like this before," says Brad smith of the Center for Biosecurity. The Department of Homeland security must first decide what "designated threats" to target and then the Department of Health commissions drugs or vaccines designed to protect against them. So far the diseases it has picked extend to anthrax, botulism and smallpox.

This targeted "one bug, one drug" approach is, however, seen by some biodefence specialists as fundamentally misguided. Ken alibek, head of the soviet and then Russian bacterial weapons programme until 1992, says it allows attackers to create pathogens that evade or resist each remedy as fast as it is developed. "Based on the former soviet model, it takes three to four years to engineer a drug-resistant o
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-611-1210
New Scientist
5-Oct-2006


Page: 1 2 3

Related biology news :

1. Global community listens to TAU genetic researcher at EU Conference on Hearing Loss
2. Global warming is evaporating Arctic ponds, new study shows
3. Global heartbeat control suggests therapy for beating heart failure
4. Global survey of lizards reveals greater abundance of animals on islands than on mainland ecosystems
5. Global ocean sampling expedition
6. Global Nephrology gathers in Rio
7. Global study concludes attack rate of flu in kids is 55 percent lower with nasal spray vaccine
8. Global warming of the future is projected by ancient carbon emissions
9. Global warming is reducing ocean life, increasing atmospheric carbon dioxide, say scientists
10. Global warming will reduce ocean productivity, marine life
11. Global malaria map key weapon in fight against malaria, scientists say

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting ... are setting a new clinical standard in telehealth thanks ... By leveraging the higi platform, IMPOWER patients can routinely ... pulse and body mass index, and, when they opt ... and convenient visit to a local retail location at ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, into ... for over 35 years, is proud to add Target to its list of ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , June 23, 2016 Houston ... with the Cy-Fair Sports Association to serve as ... the agreement, Houston Methodist Willowbrook will provide sponsorship ... and connectivity with association coaches, volunteers, athletes and ... with the Cy-Fair Sports Association and to bring ...
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
Cached News: